子宮筋腫塞栓術装置の世界市場レポート 2025年

子宮筋腫塞栓術の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.4％で70億4,000万米ドルに成長します。予測期間の成長は、非侵襲的治療に対する意識の高まり、ヘルスケアサービスの世界の拡大、女性ヘルスケア構想の高まり、集学的治療との統合、外来サービスの拡大などに起因すると考えられます。予測期間における主な動向としては、低侵襲治療法の採用増加、塞栓剤の進歩、個別化治療アプローチ、外来UFE治療への注力、画像技術の統合、生体吸収性塞栓剤の調査などが挙げられます。

低侵襲手術に対する需要の高まりが子宮筋腫塞栓術装置市場の成長を牽引すると予想されます。低侵襲手術は、小さな切開や自然な開口部を用いて、患者の身体への外傷を最小限に抑えながら、内臓や組織、構造物にアクセスし、治療するものです。子宮筋腫塞栓装置は、侵襲を最小限に抑えながら子宮筋腫を効果的に治療することで、これらの処置において重要な役割を果たしています。これらの特殊な装置は、小さな切開創を使用するように設計されており、周辺組織への影響を軽減し、侵襲の少ない医療への嗜好の高まりに応えることで、最終的に患者の予後を改善します。例えば、2023年8月、米国を拠点とする形成外科と美容医療の団体であるThe Aesthetic Societyは、米国人が美容整形に費やした金額は118億米ドルを超え、前年比2％増を記録したと報告しました。このように、低侵襲手術に対する需要の高まりが、子宮筋腫塞栓術装置市場の拡大を牽引しています。

また、高齢化の進展も子宮筋腫塞栓術市場の拡大に寄与するとみられています。65歳以上の高齢化社会では、子宮筋腫塞栓術は手術に代わる低侵襲な治療法として注目されています。この層は、過剰出血や骨盤痛のような症状の緩和を、これらの装置によって経験しています。世界保健機関（WHO）の2022年10月の報告書によると、60歳以上の世界人口は2022年に14億人に達し、2050年には21億人に倍増すると予測されています。したがって、高齢化人口の増加は子宮筋腫塞栓装置市場の促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界子宮筋腫塞栓術装置 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の子宮筋腫塞栓術装置市場：成長率分析
• 世界の子宮筋腫塞栓術装置市場の実績：規模と成長, 2019-2024
• 世界の子宮筋腫塞栓術装置市場の予測：規模と成長, 2024-2029, 2034F
• 世界子宮筋腫塞栓術装置総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の子宮筋腫塞栓術装置市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外科手術の技術
• 腹腔鏡技術
• アブレーション技術
• 塞栓術
• 世界の子宮筋腫塞栓術装置市場治療方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 侵襲的治療
• 低侵襲治療
• 非侵襲的治療
• 世界の子宮筋腫塞栓術装置市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 外来手術センター
• 世界の子宮筋腫塞栓術装置市場、手術法の細分化、種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 開腹手術
• 子宮筋腫摘出術
• 世界の子宮筋腫塞栓術装置市場腹腔鏡手術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腹腔鏡下子宮筋腫摘出術
• 腹腔鏡下子宮摘出術
• 世界の子宮筋腫塞栓術装置市場、アブレーション技術のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高周波アブレーション
• マイクロ波アブレーション
• 凍結療法
• 世界の子宮筋腫塞栓術装置市場、塞栓術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経カテーテル動脈塞栓術（TAE）
• 子宮動脈塞栓術（UAE）

第7章 地域別・国別分析

• 世界の子宮筋腫塞栓術装置市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の子宮筋腫塞栓術装置市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 子宮筋腫塞栓術装置市場：競合情勢
• 子宮筋腫塞栓術装置市場：企業プロファイル
  • Johnson and Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Stryker Corporation
• Boston Scientific Corporation
• GE HealthCare Technologies Inc.
• Olympus Corporation
• Terumo Corporation
• Smith and Nephew plc.
• Ethicon Inc.
• Hologic Inc.
• CooperSurgical Inc.
• Ferring B.V.
• Cook Medical Inc.
• Karl Storz GmbH
• Merit Medical Systems
• CONMED Corporation
• Amsino International Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 子宮筋腫塞栓術装置市場2029：新たな機会を提供する国
• 子宮筋腫塞栓術装置市場2029：新たな機会を提供するセグメント
• 子宮筋腫塞栓術装置市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A uterine fibroid embolization device is a medical device used in the treatment of noncancerous tumors, specifically uterine fibroids, through a minimally invasive procedure. Uterine fibroids are benign growths in the uterus, and this device functions by restricting the blood supply to these fibroids, causing them to shrink and ultimately disappear.

The main types of technologies associated with uterine fibroid embolization devices include surgical techniques, laparoscopic techniques, ablation techniques, and embolization techniques. Surgical techniques involve specific methods and procedures employed by medical professionals. These devices are utilized in various treatment modes, including invasive, minimally invasive, and non-invasive treatments. Additionally, they find application in diverse healthcare settings such as hospitals, clinics, and ambulatory surgical centers.

The uterine fibroid embolization device market research report is one of a series of new reports from The Business Research Company that provides uterine fibroid embolization device market statistics, including uterine fibroid embolization device industry global market size, regional shares, competitors with a uterine fibroid embolization device market share, detailed uterine fibroid embolization device market segments, market trends and opportunities, and any further data you may need to thrive in the uterine fibroid embolization device industry. This uterine fibroid embolization device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The uterine fibroid embolization devices market size has grown strongly in recent years. It will grow from $5.62 billion in 2024 to $5.93 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing incidence of uterine fibroids, preference for non-surgical alternatives, awareness and education initiatives, focus on women's health, shift towards outpatient procedures, physician training programs.

The uterine fibroid embolization devices market size is expected to see steady growth in the next few years. It will grow to $7.04 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to increasing awareness of non-invasive treatments, global expansion of healthcare services, rise in female healthcare initiatives, integration with multidisciplinary care, expansion of outpatient services. Major trends in the forecast period include increasing adoption of minimally invasive procedures, advancements in embolic agents, personalized treatment approaches, focus on outpatient ufe procedures, integration of imaging technologies, research on bioresorbable embolic agents.

The increasing demand for minimally invasive surgeries is expected to drive the growth of the uterine fibroid embolization device market. Minimally invasive surgeries involve using small incisions or natural body openings to access and treat internal organs, tissues, or structures, minimizing trauma to the patient's body. Uterine fibroid embolization devices play a crucial role in these procedures by effectively treating uterine fibroids while keeping invasiveness to a minimum. These specialized devices are designed to use small incisions, reducing the impact on surrounding tissues, and catering to the rising preference for less invasive medical treatments, ultimately improving patient outcomes. For example, in August 2023, The Aesthetic Society, a US-based organization in plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, marking a 2% increase from the previous year. Thus, the growing demand for minimally invasive surgeries is driving the expansion of the uterine fibroid embolization device market.

The growing aging population is also expected to contribute to the expansion of the uterine fibroid embolization devices market. The aging population, representing individuals aged 65 years and older, benefits from uterine fibroid embolization devices as a minimally invasive alternative to surgery for addressing symptomatic fibroids. This demographic experiences relief from symptoms such as excessive bleeding and pelvic pain through these devices. According to the World Health Organization's October 2022 report, the global population aged 60 years and older reached 1.4 billion in 2022, and by 2050, it is projected to double to 2.1 billion. Therefore, the increasing aging population acts as a driver for the uterine fibroid embolization devices market.

Major companies in the uterine fibroid embolization device market are focusing on developing innovative products such as the TruClear system to address the growing demand for minimally invasive treatments for uterine fibroids, aiming to enhance safety and efficacy. The TruClear system, launched by Medtronic Private Limited in November 2022, is a mechanical hysteroscopic tissue removal system used for treating intrauterine abnormalities. It features a flexible catheter inserted through the cervix into the uterus, incorporating a spinning nitinol wire loop, continuous inflow and outflow, integrated suction, and high-definition imaging, contributing to the precision and safety of uterine fibroid treatment.

In October 2024, Hologic Inc., a US-based medical technology company, acquired Gynesonics for $350 million. Through this acquisition, Hologic seeks to expand its range of minimally invasive treatment options for women's health, with a focus on managing uterine fibroids and heavy menstrual bleeding. Gynesonics Inc. is a US-based medical technology company specializing in the development of minimally invasive solutions for treating symptomatic uterine fibroids.

Major companies operating in the uterine fibroid embolization device market report are Johnson and Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Siemens Healthineers Ltd., Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, GE HealthCare Technologies Inc., Olympus Corporation, Terumo Corporation, Smith and Nephew plc., Ethicon Inc., Hologic Inc., CooperSurgical Inc., Ferring B.V., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Amsino International Inc., Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., INSIGHTEC Ltd., Hironic Co.Ltd., Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC, Hitachi Medical Corporation

North America was the largest region in the uterine fibroid embolization device market in 2024. The regions covered in the uterine fibroid embolization device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the uterine fibroid embolization device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The uterine fibroid embolization device market consists of revenues earned by entities by provide services such as minimally invasive procedures, non-invasive procedures, minimally invasive procedures, radiofrequency ablation, medication and hormonal therapy, and embolization procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The uterine fibroid embolization device market also includes sales of medications, hysteroscopic devices, laparoscopic devices, radiofrequency ablation devices, endometrial ablation devices, hysterectomy devices, and robotic surgical systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Uterine Fibroid Embolization Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on uterine fibroid embolization device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for uterine fibroid embolization device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The uterine fibroid embolization device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Surgical Techniques; Laparoscopic Techniques; Ablation Techniques; Embolization Techniques
• 2) By Mode Of Treatment: Invasive Treatment; Minimally Invasive Treatment; Non-Invasive Treatment
• 3) By End User: Hospitals; Clinics; Ambulatory Surgical Center
• Subsegments:
• 1) By Surgical Techniques: Open Surgery; Myomectomy
• 2) By Laparoscopic Techniques: Laparoscopic Myomectomy; Laparoscopic Hysterectomy
• 3) By Ablation Techniques: Radiofrequency Ablation; Microwave Ablation; Cryoablation
• 4) By Embolization Techniques: Transcatheter Arterial Embolization (TAE); Uterine Artery Embolization (UAE)
• Companies Mentioned: Johnson and Johnson Pvt Ltd.; Abbott Laboratories; Medtronic plc.; Siemens Healthineers Ltd.; Koninklijke Philips N.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Uterine Fibroid Embolization Device Market Characteristics

3. Uterine Fibroid Embolization Device Market Trends And Strategies

4. Uterine Fibroid Embolization Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Uterine Fibroid Embolization Device Growth Analysis And Strategic Analysis Framework

• 5.1. Global Uterine Fibroid Embolization Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Uterine Fibroid Embolization Device Market Growth Rate Analysis
• 5.4. Global Uterine Fibroid Embolization Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Uterine Fibroid Embolization Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Uterine Fibroid Embolization Device Total Addressable Market (TAM)

6. Uterine Fibroid Embolization Device Market Segmentation

• 6.1. Global Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Techniques
• Laparoscopic Techniques
• Ablation Techniques
• Embolization Techniques
• 6.2. Global Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Invasive Treatment
• Minimally Invasive Treatment
• Non-Invasive Treatment
• 6.3. Global Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgical Center
• 6.4. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Surgical Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Open Surgery
• Myomectomy
• 6.5. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Laparoscopic Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laparoscopic Myomectomy
• Laparoscopic Hysterectomy
• 6.6. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Ablation Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• 6.7. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Embolization Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcatheter Arterial Embolization (TAE)
• Uterine Artery Embolization (UAE)

7. Uterine Fibroid Embolization Device Market Regional And Country Analysis

• 7.1. Global Uterine Fibroid Embolization Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Uterine Fibroid Embolization Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Uterine Fibroid Embolization Device Market

• 8.1. Asia-Pacific Uterine Fibroid Embolization Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Uterine Fibroid Embolization Device Market

• 9.1. China Uterine Fibroid Embolization Device Market Overview
• 9.2. China Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Uterine Fibroid Embolization Device Market

• 10.1. India Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Uterine Fibroid Embolization Device Market

• 11.1. Japan Uterine Fibroid Embolization Device Market Overview
• 11.2. Japan Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Uterine Fibroid Embolization Device Market

• 12.1. Australia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Uterine Fibroid Embolization Device Market

• 13.1. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Uterine Fibroid Embolization Device Market

• 14.1. South Korea Uterine Fibroid Embolization Device Market Overview
• 14.2. South Korea Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Uterine Fibroid Embolization Device Market

• 15.1. Western Europe Uterine Fibroid Embolization Device Market Overview
• 15.2. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Uterine Fibroid Embolization Device Market

• 16.1. UK Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Uterine Fibroid Embolization Device Market

• 17.1. Germany Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Uterine Fibroid Embolization Device Market

• 18.1. France Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Uterine Fibroid Embolization Device Market

• 19.1. Italy Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Uterine Fibroid Embolization Device Market

• 20.1. Spain Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Uterine Fibroid Embolization Device Market

• 21.1. Eastern Europe Uterine Fibroid Embolization Device Market Overview
• 21.2. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Uterine Fibroid Embolization Device Market

• 22.1. Russia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Uterine Fibroid Embolization Device Market

• 23.1. North America Uterine Fibroid Embolization Device Market Overview
• 23.2. North America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Uterine Fibroid Embolization Device Market

• 24.1. USA Uterine Fibroid Embolization Device Market Overview
• 24.2. USA Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Uterine Fibroid Embolization Device Market

• 25.1. Canada Uterine Fibroid Embolization Device Market Overview
• 25.2. Canada Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Uterine Fibroid Embolization Device Market

• 26.1. South America Uterine Fibroid Embolization Device Market Overview
• 26.2. South America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Uterine Fibroid Embolization Device Market

• 27.1. Brazil Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Uterine Fibroid Embolization Device Market

• 28.1. Middle East Uterine Fibroid Embolization Device Market Overview
• 28.2. Middle East Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Uterine Fibroid Embolization Device Market

• 29.1. Africa Uterine Fibroid Embolization Device Market Overview
• 29.2. Africa Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Uterine Fibroid Embolization Device Market Competitive Landscape And Company Profiles

• 30.1. Uterine Fibroid Embolization Device Market Competitive Landscape
• 30.2. Uterine Fibroid Embolization Device Market Company Profiles
  • 30.2.1. Johnson and Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Uterine Fibroid Embolization Device Market Other Major And Innovative Companies

• 31.1. Stryker Corporation
• 31.2. Boston Scientific Corporation
• 31.3. GE HealthCare Technologies Inc.
• 31.4. Olympus Corporation
• 31.5. Terumo Corporation
• 31.6. Smith and Nephew plc.
• 31.7. Ethicon Inc.
• 31.8. Hologic Inc.
• 31.9. CooperSurgical Inc.
• 31.10. Ferring B.V.
• 31.11. Cook Medical Inc.
• 31.12. Karl Storz GmbH
• 31.13. Merit Medical Systems
• 31.14. CONMED Corporation
• 31.15. Amsino International Inc.

32. Global Uterine Fibroid Embolization Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Uterine Fibroid Embolization Device Market

34. Recent Developments In The Uterine Fibroid Embolization Device Market

35. Uterine Fibroid Embolization Device Market High Potential Countries, Segments and Strategies

• 35.1 Uterine Fibroid Embolization Device Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Uterine Fibroid Embolization Device Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Uterine Fibroid Embolization Device Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer